Brief: Aslan Pharmaceuticals Announces Expansion Of Its Collaboration With Zenyaku
02/05/2024 14:06
May 2 (Reuters) - Aslan Pharmaceuticals Ltd 7A90y.BE :
* ASLAN PHARMACEUTICALS ANNOUNCES EXPANSION OF ITS
COLLABORATION
WITH ZENYAKU TO INVESTIGATE THE BIOLOGY UNDERLYING DIFFERENTIAL
EFFECTS OF EBLASAKIMAB COMPARED TO OTHER BIOLOGICS
Source text for Eikon: ID:nGNX8Sv33j
Further company coverage: 7A90y.BE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aslan Pharmaceuticals
See all newsBrief: Aslan Pharmaceuticals Announces Plan To Implement ADS Ratio Change
Brief: Aslan Pharmaceuticals Ltd Files For Shelf Of Up To 61.9 Million Ordinary Shares By Selling Stockholder - SEC Filing
Brief: Aslan Pharmaceuticals Announces Expansion Of Its Collaboration With Zenyaku
Brief: Aslan Pharmaceuticals Announces Positive Interim Results From Phase 2 Study Of Eblasakimab
Brief: ASLAN Pharmaceuticals To Sell ADSs Having An Aggregate Offering Price Of Up To $12 Mln